pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
545
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
LMN-201
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Lumen Bioscience Inc
0
catalysts
Phase 3
LNS-8801
Metastatic Melanoma
Linnaeus Therapeutics Inc
0
catalysts
Phase 3
MC-1
heart failure
$MCUJF
MEDICURE INC
0
catalysts
Phase 3
← prev
page 4 of 19
next →
131
Pain
89
Neurology
1
MH-002
Ulcerative Colitis
MRM Health NV
0
catalysts
Phase 3
MK-1406
Pandemic Influenza
$MRK
Merck & Co., Inc.
0
catalysts
Phase 3
Maci
Articular Cartilage Defect
$VCEL
Vericel Corp
0
catalysts
Phase 3
Melpida
Paraplegia
Elpida Therapeutics
0
catalysts
Phase 3
Multikine
Head And Neck Squamous Cell Carcinoma (HNSC)
CEL-SCI Corp
0
catalysts
Phase 3
NA-831
Traneurocin
Alzheimer's Disease
Biomed Industries Inc
0
catalysts
Phase 3
NA-921
Rett Syndrome
Biomed Industries Inc
0
catalysts
Phase 3
NA-941
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Biomed Industries Inc
0
catalysts
Phase 3
NGN-401
Rett Syndrome
$NGNE
Neurogene Inc.
0
catalysts
Phase 3
NP-028
Coronavirus Disease 2019 (COVID-19)
$EBS
Emergent BioSolutions Inc.
0
catalysts
Phase 3
NPG-2044
Ovarian Cancer
Novita Pharmaceuticals Inc
0
catalysts
Phase 3
NRTX-1001
Epilepsy
Neurona Therapeutics Inc
0
catalysts
Phase 3
NTO-1151
Triapine
Cervical Cancer
Ribonucleotide reductase
Resilience Government Services Inc
0
catalysts
Phase 3
NTX-001
Peripheral Nerve Injury
Neuraptive Therapeutics Inc
0
catalysts
Phase 3
NVD-003
Pseudarthrosis (Nonunion of Fracture/Pseudoarthrosis)
Novadip Biosciences SA
0
catalysts
Phase 3
Neuronata-R
Amyotrophic Lateral Sclerosis
Corestemchemon Inc
0
catalysts
Phase 3
OCU-410ST
Juvenile Macular Degeneration (Stargardt Disease)
$OCGN
Ocugen, Inc.
0
catalysts
Phase 3
OPGx-LCA5
Leber Congenital Amaurosis (LCA)
$IRD
Opus Genetics, Inc.
0
catalysts
Phase 3
OPL-015
Pain
Overseas Pharmaceuticals Ltd
0
catalysts
Phase 3
OSE-2101
Tedopi
Non-Small Cell Lung Cancer
OSE Immunotherapeutics SA
0
catalysts
Phase 3
OncoVAX
Colon Cancer
Vaccinogen Inc
0
catalysts
Phase 3
PAX-101
suramin hexasodium
African Trypanosomiasis
Fibroblast growth factor 1
Kuvatris Therapeutics Inc
0
catalysts
Phase 3
PD-L1 t-haNK
Metastatic Pancreatic Cancer
$IBRX
ImmunityBio, Inc.
0
catalysts
Phase 3
PDS-0101
Hypopharyngeal Cancer
$PDSB
PDS Biotechnology Corp
0
catalysts
Phase 3
PF-06760805
Streptococcal Infections
$PFE
PFIZER INC
0
catalysts
Phase 3
PF-614
Post-Operative Pain
$ENSC
Ensysce Biosciences, Inc.
0
catalysts
Phase 3
PHVS-416
deucrictibant
Angioedema
Pharvaris NV
0
catalysts
